GlaxoSmithKline | Чистый Доход



Net Income Изменить Дата
AbbVie USD -22000000 1.58B 2024-12
Alcon AG USD 284M 21M 2024-12
Almirall EUR 7.99M 590K 2024-06
Amgen USD 627M 2.2B 2024-12
argenx SE USD 774.16M 682.75M 2024-12
AstraZeneca USD 1.5B 71M 2024-12
Bayer EUR -335000000 3.85B 2024-12
Biogen USD 266.7M 121.8M 2024-12
Bristol-Myers Squibb USD 72M 1.14B 2024-12
Eli Lilly USD 4.41B 3.44B 2024-12
Fresenius EUR 240M 86M 2024-12
Fresenius Medical Care EUR 66.9M 146.1M 2024-12
Galapagos EUR 25.31M 75.74M 2024-12
Genmab DKK 3.84B 2.58B 2024-12
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 414M 472M 2024-12
Glaxosmithkline GBP 414M 472M 2024-12
GRIFOLS EUR 68.97M 17.28M 2024-12
Hikma Pharmaceutical USD 226M 167M 2024-06
Lonza CHF 329M 85M 2024-06
Merck EUR 809M 202M 2024-09
Merck USD 3.74B 586M 2024-12
Novartis USD 2.82B 371M 2024-12
Novo Nordisk 27.3B 7.25B 2024-09
Orion EUR 73.4M 87.4M 2024-12
Pfizer USD 410M 4.06B 2024-12
Philips EUR -335000000 516M 2024-12
Recordati EUR 113.03M 11.25M 2024-09
Regeneron Pharmaceuticals USD 917.7M 422.9M 2024-12
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 2.82B 1.7B 2024-09
Smith & Nephew USD 198M 16M 2024-12
UCB EUR 104M 72M 2024-06



GlaxoSmithKline Чистый Доход - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Mar 2025.